Investigating blood markers in lung hydatid cyst patients
The Importance of Inflammatory Markers Calculated From Preoperative and Postoperative Peripheral Blood Results in the Diagnosis and Treatment of Patients Operated for Hydatid Cyst of the Lung (Lung Echinococcus Granulosus)
Yuzuncu Yıl University · NCT06281522
This study is testing how certain blood markers can help doctors better diagnose and manage lung hydatid cysts in patients before and after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 54 (estimated) |
| Ages | 18 Years to 83 Years |
| Sex | All |
| Sponsor | Yuzuncu Yıl University (other) |
| Locations | 1 site (Van) |
| Trial ID | NCT06281522 on ClinicalTrials.gov |
What this trial studies
This study examines the role of inflammatory markers in the diagnosis and management of pulmonary hydatid cysts by analyzing preoperative and postoperative blood results. It focuses on various blood components, including eosinophils, neutrophils, lymphocytes, and platelets, as well as specific ratios that may aid in clinical decision-making. The research aims to fill the knowledge gap regarding laboratory values in patients with lung hydatid cysts, providing a cost-effective and reproducible method for improving diagnosis and treatment. The study is conducted at a hospital specializing in thoracic surgery.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with lung hydatid cysts who are hospitalized in the Thoracic Surgery Service between January 1, 2022, and December 1, 2023.
Not a fit: Patients with conditions other than lung hydatid cysts admitted to the Thoracic Surgery Service will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of diagnosing and managing lung hydatid cysts, leading to better patient outcomes.
How similar studies have performed: While there is extensive data on hydatid liver cysts, this approach to studying lung hydatid cysts is relatively novel and has limited prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between January 1, 2022 - December 1, 2023, patients with hydatid cyst of the lung who were hospitalized in the Thoracic Surgery Service Exclusion Criteria: * Between January 1, 2022 and December 1, 2023, other patients admitted to the Thoracic Surgery Service
Where this trial is running
Van
- University of Health Sciences, Van Training and Research Hospital — Van, Turkey (RECRUITING)
Study contacts
- Study coordinator: Abdullah ADIYAMAN
- Email: aadyaman@hotmail.com
- Phone: +905465880056
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lung Hydatid Cyst, neutrophils,, lymphocytes,, platelets